Why is the Medibank (ASX:MPL) share price struggling lately?

It hit a 52-week high in early September but the Medibank share price has been struggling ever since.

| More on:
Three medical staffers sit at a table and chat happily wearing hospital scrubs

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medibank Private Ltd (ASX: MPL) share price has been struggling lately.

Since reaching a 52-week high of $3.62 a share back on 7 September, the Medibank share price has fallen by more than 2% to sit at $3.55 a share so far today.

Even so, the company remains up by 16.6% year to date, and up a very healthy 38.3% over the past 12 months.

But why have Medibank shares been struggling over the past week or two?

Medibank share price struggles after ex-dividend date

Well, one anchor on the Medibank share price last week was its ex-dividend date.

In Medibank's FY21 earnings report, which it delivered last month, the company announced a final dividend for FY21 of 6.9 cents per share, fully franked.

That payment will hit investors' pockets on 30 September. But it left the Medibank share price on 8 September when the shares went ex-dividend.

This is the primary reason why the Medibank share price has struggled ever since.

Even so, shareholders might not be too concerned. This final dividend was a boost from FY20's final payout of 6.3 cents per share.

Another potential reason for Medibank's recent struggle is some private health sector news.

According to a report on news.com.au this week, private health insurers like Medibank have been offering their customers 'COVID discounts'.

The report states that "some of the largest insurers [are handing] back funds collected in premiums that didn't get paid in claims due to Covid restrictions".

This includes Medibank, which the report states has "also committed to returning around $105 million in Covid-19 net claims through premium relief for Australian Medibank and ahm customers with an active hospital and/or extras policy between the 2020/21 financial year".

Whilst this news may please Medibank's customers, it is still unquestionably deleterious to the company's overall finances. This may have been deterring investors in recent times.

At the current Medibank Private share price of $3.55, the company has a market capitalisation of $9.78 billion. It also has a price-to-earnings (P/E) ratio of 22.16 and a dividend yield of 3.58%

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

CSL share price leaping higher amid $1.9 billion funding news

ASX 200 investors are bidding up the CSL share price on Wednesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

Guess which ASX 200 healthcare share is jumping 7% on a guidance update

This healthcare share is performing better than expected in FY 2024.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Earnings Results

Chemist Warehouse merger target Sigma reports 149% FY24 profit jump

This could be the last set of results from Sigma as we know it if its merger is approved.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

1 ASX healthcare stock that looks severely undervalued

I think this stock looks too cheap to miss.

Read more »

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Own Medibank shares? Here's why it's a rewarding day for you

Shareholders are getting a healthy boost today.

Read more »

Health professional looking at a laptop.
Healthcare Shares

Are CSL shares a must-buy in March?

Let's see what analysts are saying about this high-quality company.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

This ASX healthcare stock is up 72% on FDA news and 'historic moment'

Huge gains are been recorded by this stock on Tuesday. But why?

Read more »